Table 1 Patient and tumour characteristics according to country (2001–2010)

From: Treatment and survival of rectal cancer patients over the age of 80 years: a EURECCA international comparison

Characteristics

Belgium (n = 3627)a

Denmark (n = 2444)

Netherlands (n = 6465)

Norway (n = 2925)

Sweden (n = 4173)

Rectal cancer

Sex

 Male

1766 (48.7)

1206 (49.4)

3022 (46.7)

1427 (48.8)

2175 (52.1)

 Female

1861 (51.3)

1238 (50.6)

3443 (53.3)

1498 (51.2)

1998 (47.9)

Age (years)

 80–84

2213 (61.0)

1368 (56.0)

3843 (59.4)

1645 (56.2)

2421 (58.0)

 85–89

1073 (29.6)

788 (32.2)

1982 (30.7)

919 (31.4)

1312 (31.4)

 90–94

278 (7.7)

249 (10.2)

559 (8.6)

302 (10.3)

372 (8.9)

 95–99

58 (1.6)

38 (1.6)

77 (1.2)

51 (1.7)

64 (1.5)

 100+

5 (0.1)

1 (0.04)

4 (0.1)

8 (0.3)

4 (0.1)

Stage

 I

631 (17.4)

375 (15.3)

1474 (22.8)

951 (32.5)

732 (17.5)

 II

858 (23.7)

550 (22.5)

1618 (25.0)

499 (17.1)

879 (21.1)

 III

918 (25.3)

421 (17.2)

1331 (20.6)

539 (18.4)

887 (21.3)

 IV

457 (12.6)

640 (26.2)

996 (15.4)

497 (17.0)

698 (16.7)

 Unknown

763 (21.0)

458 (18.7)

1046 (16.2)

439 (15.0)

977 (23.4)

Grade

 I

562 (15.5)

b

310 (4.8)

b

128 (3.1)

 II

1780 (49.1)

b

3026 (46.8)

b

1005 (24.1)

 III

434 (12.0)

b

647 (10.0)

b

159 (3.8)

 Unknown

851 (23.5)

b

2482 (38.4)

b

2881 (69.0)

  1. Data are presented as n(%)
  2. aOnly data of the period 2004–2010 were available
  3. bNot registered in data set